Investigation of an Outbreak of Equine Herpesvirus-1 Myeloencephalopathy in a Population of Aged Working Equids

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2025 Jan 8

PMID 39772269

Authors

Nicola Pusterla

Kaila Lawton

Samantha Barnum

Kelly Ross

Kris Purcell

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to describe an outbreak of equine herpesvirus-1 myeloencephalopathy (EHM) in a population of aged equids. The outbreak was linked to the introduction of five healthy non-resident horses 15 days prior to the first case of acute recumbency. This fulminant EHM outbreak was predisposed by the grouping of the 33 unvaccinated animals in two large pens with shared water and feed troughs. Fourteen horses (42.4%) developed neurological deficits within the first week of the outbreak. Four additional equids developed fever and respiratory signs (EHV-1 infection), while fifteen horses remained healthy. EHM was supported by the detection of EHV-1 N in blood ( = 11) and/or nasal secretions (9). Three out of four equids with EHV-1 infection and two out of fifteen healthy horses tested qPCR-positive for EHV-1. All animals were managed in the field. EHM and EHV-1 equids were treated with a combination of antiherpetic, anti-inflammatory, and antithrombotic drugs. Six out of fourteen EHM horses (42.9%) were euthanized because of recumbence and the inability to stand with assistance or vestibular signs. Anti-EHV-1 total IgG and IgG 4/7 levels in acute serum samples showed no significant difference amongst the three disease groups ( > 0.05); however, antibody levels rose significantly between acute and convalescent serum samples for EHM ( = 0.0001) and EHV-1 equids ( = 0.02). This outbreak highlights a very high EHM attack and fatality rate in a population of aged equids and rapid spread of EHV-1, as the population shared common pens and feeding practices. The outbreak also showed that EHM cases can be managed in the field when referral to a hospital is not an option.

References

Pusterla N, Soboll Hussey G, Goehring L . Equine Herpesvirus-1 Myeloencephalopathy. Vet Clin North Am Equine Pract. 2022; 38(2):339-362. DOI: 10.1016/j.cveq.2022.05.006. View

Eady N, Holmes C, Schnabel C, Babasyan S, Wagner B . Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies. J Virol. 2024; 98(6):e0025024. PMC: 11237562. DOI: 10.1128/jvi.00250-24. View

Goehring L, Dorman D, Osterrieder K, Burgess B, Dougherty K, Gross P . Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review. J Vet Intern Med. 2024; 38(3):1892-1905. PMC: 11099759. DOI: 10.1111/jvim.17016. View

Pusterla N, Mapes S, Wilson W . Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases. Vet Rec. 2008; 162(22):728-9. DOI: 10.1136/vr.162.22.728. View

Wilcox A, Barnum S, Wademan C, Corbin R, Escobar E, Hodzic E . Frequency of Detection of Respiratory Pathogens in Clinically Healthy Show Horses Following a Multi-County Outbreak of Equine Herpesvirus-1 Myeloencephalopathy in California. Pathogens. 2022; 11(10). PMC: 9612363. DOI: 10.3390/pathogens11101161. View

Pusterla N, Barnum S, Miller J, Varnell S, Dallap-Schaer B, Aceto H . Investigation of an EHV-1 Outbreak in the United States Caused by a New H Genotype. Pathogens. 2021; 10(6). PMC: 8231618. DOI: 10.3390/pathogens10060747. View

Allen G . Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res. 2008; 69(12):1595-600. DOI: 10.2460/ajvr.69.12.1595. View

Estell K, Dawson D, Magdesian K, Swain E, Laing S, Siso S . Quantitative molecular viral loads in 7 horses with naturally occurring equine herpesvirus-1 infection. Equine Vet J. 2014; 47(6):689-93. DOI: 10.1111/evj.12351. View

Osterrieder K, Dorman D, Burgess B, Goehring L, Gross P, Neinast C . Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis. J Vet Intern Med. 2023; 38(3):1858-1871. PMC: 11099739. DOI: 10.1111/jvim.16895. View

10.

Goodman L, Wagner B, Flaminio M, Sussman K, Metzger S, Holland R . Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine. 2006; 24(17):3636-45. DOI: 10.1016/j.vaccine.2006.01.062. View

11.

Klouth E, Zablotski Y, Petersen J, de Bruijn M, Grondahl G, Muller S . Epidemiological Aspects of Equid Herpesvirus-Associated Myeloencephalopathy (EHM) Outbreaks. Viruses. 2022; 14(11). PMC: 9695031. DOI: 10.3390/v14112576. View

12.

Burgess B, Tokateloff N, Manning S, Lohmann K, Lunn D, Hussey S . Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada. J Vet Intern Med. 2012; 26(2):384-92. DOI: 10.1111/j.1939-1676.2012.00885.x. View

13.

Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A . SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020; 8(9):e70. PMC: 7836878. DOI: 10.1016/S2213-2600(20)30354-4. View

14.

Pronost S, Legrand L, Pitel P, Wegge B, Lissens J, Freymuth F . Outbreak of equine herpesvirus myeloencephalopathy in France: a clinical and molecular investigation. Transbound Emerg Dis. 2011; 59(3):256-63. DOI: 10.1111/j.1865-1682.2011.01263.x. View

15.

Pusterla N, Mapes S, Wademan C, White A, Estell K, Swain E . Investigation of the role of mules as silent shedders of EHV-1 during an outbreak of EHV-1 myeloencephalopathy in California. Vet Rec. 2012; 170(18):465. DOI: 10.1136/vr.100598. View

16.

Giessler K, Goehring L, Jacob S, Davis A, Esser M, Lee Y . Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses. J Gen Virol. 2024; 105(5). PMC: 11170125. DOI: 10.1099/jgv.0.001987. View

17.

Traub-Dargatz J, Pelzel-McCluskey A, Creekmore L, Geiser-Novotny S, Kasari T, Wiedenheft A . Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak. J Vet Intern Med. 2013; 27(2):339-46. DOI: 10.1111/jvim.12051. View

18.

Klouth E, Zablotski Y, Goehring L . Apparent Breed Predilection for Equid Herpesvirus-1-Associated Myeloencephalopathy (EHM) in a Multiple-Breed Herd. Pathogens. 2021; 10(5). PMC: 8145278. DOI: 10.3390/pathogens10050537. View

19.

Pusterla N, Wilson W, Mapes S, Finno C, Isbell D, Arthur R . Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet J. 2007; 179(2):230-9. DOI: 10.1016/j.tvjl.2007.09.018. View

20.

Oladunni F, Horohov D, Chambers T . EHV-1: A Constant Threat to the Horse Industry. Front Microbiol. 2019; 10:2668. PMC: 6901505. DOI: 10.3389/fmicb.2019.02668. View